Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gualandi

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Haematologica|November 27, 1998
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapseP Zikos, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Haematologica|March 1, 1997
Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSFA Bacigalupo, G Piaggio, M Podestà, et al.
Bone Marrow Transplantation|January 23, 2002
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)A Bacigalupo, R Oneto, T Lamparelli, et al.
Haematologica|June 22, 2001
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograftC di Grazia, A M Raiola, M T Van Lint, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
Bone Marrow Transplantation|October 2, 2007
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow upA Bacigalupo, A M Raiola, T Lamparelli, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 10, 2002
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)A Bacigalupo, R Oneto, B Bruno, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Haematologica|November 27, 1998
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapseP Zikos, M T Van Lint, T Lamparelli, et al.
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
British Journal of Haematology|January 29, 2000
The combined effect of total body irradiation (TBI) and cyclosporin A (CyA) on the risk of relapse in patients with acute myeloid leukaemia undergoing allogeneic bone marrow transplantationA Bacigalupo, V Vitale, R Corvò, et al.
Haematologica|March 1, 1997
Early hemopoietic progenitors in the peripheral blood of patients with severe aplastic anemia (SAA) after treatment with antilymphocyte globulin (ALG), cyclosporin-A and G-CSFA Bacigalupo, G Piaggio, M Podestà, et al.
Bone Marrow Transplantation|January 23, 2002
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)A Bacigalupo, R Oneto, T Lamparelli, et al.
Haematologica|June 22, 2001
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograftC di Grazia, A M Raiola, M T Van Lint, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 20, 2010
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipientsM Mikulska, V Del Bono, R Prinapori, et al.
Bone Marrow Transplantation|October 2, 2007
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow upA Bacigalupo, A M Raiola, T Lamparelli, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 10, 2002
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)A Bacigalupo, R Oneto, B Bruno, et al.
Pageof 14